Europa- Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Atripla til Bristol- Myers Squibb And Gilead Sciences Limited den 13. december 2007.
The European Commission granted a marketing authorisation valid throughout the EU for Atripla to Bristol-Myers Squibb And Gilead Sciences Limited on 13 December 2007.